254 related articles for article (PubMed ID: 10846737)
1. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
[TBL] [Abstract][Full Text] [Related]
2. [Candida dubliniensis studies and isolation of Candida types in oropharyngeal specimens from oncologic patients].
Tekeli A; Dolapçi I; Cesur S; Tekeli E; Içli F
Mikrobiyol Bul; 2002 Jan; 36(1):57-63. PubMed ID: 12476767
[TBL] [Abstract][Full Text] [Related]
3. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
[TBL] [Abstract][Full Text] [Related]
4. Identification of Candida dubliniensis in a HIV-positive South African population.
Fisher JM; Basson NJ; van Zyl A
SADJ; 2001 Dec; 56(12):599-601. PubMed ID: 11887446
[TBL] [Abstract][Full Text] [Related]
5. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
6. Identification of Candida dubliniensis in a prospective study of patients in the United States.
Jabra-Rizk MA; Baqui AA; Kelley JI; Falkler WA; Merz WG; Meiller TF
J Clin Microbiol; 1999 Feb; 37(2):321-6. PubMed ID: 9889211
[TBL] [Abstract][Full Text] [Related]
7. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
[TBL] [Abstract][Full Text] [Related]
8. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
9. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
10. Candida dubliniensis: an emerging opportunistic pathogen.
Sullivan D; Coleman D
Curr Top Med Mycol; 1997 Dec; 8(1-2):15-25. PubMed ID: 9504063
[TBL] [Abstract][Full Text] [Related]
11. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
12. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.
Jabra-Rizk MA; Falkler WA; Merz WG; Baqui AA; Kelley JI; Meiller TF
J Clin Microbiol; 2000 Jun; 38(6):2423-6. PubMed ID: 10835022
[TBL] [Abstract][Full Text] [Related]
13. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
[TBL] [Abstract][Full Text] [Related]
14. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
[TBL] [Abstract][Full Text] [Related]
15. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
[TBL] [Abstract][Full Text] [Related]
16. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States.
Meiller TF; Jabra-Rizk MA; Baqui Aa; Kelley JI; Meeks VI; Merz WG; Falkler WA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Nov; 88(5):573-80. PubMed ID: 10556752
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of yeast among children in Nigeria and the United States.
Jabra-Rizk MA; Falkler WA; Enwonwu CO; Onwujekwe DI; Merz WG; Meiller TF
Oral Microbiol Immunol; 2001 Dec; 16(6):383-5. PubMed ID: 11737663
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
[TBL] [Abstract][Full Text] [Related]
19. Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count.
Erköse G; Erturan Z
Mycoses; 2007 Nov; 50(6):485-90. PubMed ID: 17944711
[TBL] [Abstract][Full Text] [Related]
20. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
